Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment

Journal of Toxicology - Clinical Toxicology

Volumn 38, Issue 4, 2000, Pages 383-387

  Mata, J E ^a   Bishop, M R ^a   Tarantolo, S R ^a   Angle, C R ^a   Swanson, S A ^a   Iversen, P L ^a  

^a AVI BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADMIUM; CHELATING AGENT; COPPER; IRON; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; ZINC;

ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; HEAVY METAL POISONING; HUMAN; IRON TRANSPORT; KIDNEY CLEARANCE;

CADMIUM; CHELATING AGENTS; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; HUMANS; INFUSIONS, INTRAVENOUS; IRON; IRON CHELATING AGENTS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; SPECTROPHOTOMETRY, ATOMIC; THIONUCLEOTIDES; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 0033914794     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100100947     Document Type: Article

References (11)

1. A risk-benefit assessment of iron-chelation therapy
2. The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells
3. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs
4. Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism
5. Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man
6. Reaction between metabolically activated acetaminophen and phosphorothioate oligonucleotides
7. Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies
8. Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part II in vivo models
9. Toxicity of oligonucleotide therapeutic agents
10. CpG motifs in bacterial DNA trigger direct B-cell activation
11. Effects of size and sequence on the iontophoretic delivery of oligonucleotides